India: approval for drug treating CKD-associated anaemia
March 7, 2022Sales and Marketing
Zydus Lifesciences received approval from the Drugs Controller General of India (DCGI) for its new drug application for Oxemia (Desidustat). …
Phase III trial into nirsevimab for RSV treatment yields positive results
March 4, 2022Medical Communications
The latest results from Sanofi and AstraZeneca’s Phase III trial nirsevimab support the vaccine’s ability to protect all infants from …
Median Technologies iBiopsy Lung Cancer Screening Software
March 4, 2022Medical Communications
Median Technologies has announced that the company has filed a regulatory submission to the FDA for its iBiopsy Lung Cancer …
Promising treatment targeting 40% mortality Candida infection
March 4, 2022Medical Communications
A Promising Innovation Medicine (PIM) designation has been awarded to rezafungin by the MHRA, for the treatment of invasive candidiasis. …
Anti-inflammatory baricitinib is a life-saving COVID-19 drug
March 4, 2022Medical Communications
UK experts say they have identified another life-saving drug that can alleviate COVID-19 illness. The anti-inflammatory baricitinib is usually used …
Risk of hospitalisation five times higher with J&J
March 3, 2022Business Services, Medical Communications
A study published in Jama Network Open has revealed that Johnson & Johnson’s coronavirus vaccine was far less effective at …
FDA grants breakthrough therapy designation to RSV vaccine
March 3, 2022Business Services, Medical Communications
The FDA has granted a Breakthrough Therapy Designation to Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, for the prevention of …
WHO recommends Merck’s COVID-19 pill
March 3, 2022Business Services, Medical Communications
WHO have recommended Merck’s pill, molnupiravir, for the treatment of COVID-19 in patients in high risk groups, such as the …
First smart connected insulin pens made available on NHS
March 2, 2022Research and Development
Today, Novo Nordisk will launch the first smart connected insulin pens to be made available on NHS prescription. The pens, …
Fera Pharmaceuticals receives Orphan Drug Designation from FDA for sickle cell treatment
March 2, 2022Research and Development
The FDA has granted an Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an …
HPV vaccines could mean only one smear test a lifetime
March 2, 2022Research and Development
A leading scientist has said that women who have the HPV vaccine may need only one smear test to prevent …
FDA share new trial guidelines to further cancer therapy development
March 2, 2022Research and Development
The FDA has issued three recommendations to industry for clinical trials, to support US President Joe Biden’s relaunch of the …
Moderna faces lawsuit over COVID-19 vaccine
March 1, 2022Manufacturing and Production
Moderna has been accused of ‘hijacking’ technology from two smaller biotech firms – Arbutus Biopharma and Genevant Sciences – to …
ELUNATE receives commercial approval in Macau
March 1, 2022Manufacturing and Production
HUTCHMED has received approval to market fruquintinib (ELUNATE in China), a selective and potent oral inhibitor of vascular endothelial growth …
FDA approves CAR-T therapy for multiple myeloma
March 1, 2022Manufacturing and Production
The FDA gas approved a therapy developed by J&J and its partner Legend Biotech, to treat relapsed or refractory multiple …
First oral diabetes treatment approved in Europe for use during pregnancy
March 1, 2022Manufacturing and Production
Merck has announced an extension to the label for metformin products in the EU – glucophage (metformin hydrochloride immediate release), …
Potential breakthrough trial for rare disease Hunter syndrome
February 28, 2022Sales and Marketing
Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the debilitating, life-limiting, rare disease mucopolysaccharidosis …
Phase III data show Dupixent reduced itch in chronic spontaneous urticaria patients
February 28, 2022Sales and Marketing
Results from a Phase III trial have revealed that adding Dupixent (dupilumab) to standard-of-care antihistamines significanty reduced itch and hives …
Urgent need to address mental health crisis among kidney patients
February 28, 2022Sales and Marketing
Kidney Research UK has released their findings from a survey of 1,000 kidney disease patients in the UK, revealing the …
Kapruvia receives positive CHMP opinion for pruritus in hemodialysis patients
February 28, 2022Sales and Marketing
The CHMP has approved Kapruvia (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in hemodialysis patients. …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
